← Back
Data updated: Mar 10, 2026
RENEW PHARMS
Pharmaceuticals
RENEW PHARMS is a pharmaceutical company with 4 FDA-approved products.
1959
Since
4
Drugs
-
Trials
15
Approved (2yr)
Key Drugs
No active drugs
Recent Activity
EPHEDRINE SULFATE 2025-12-23
DICYCLOMINE HYDROCHLORIDE 2025-09-15
Manufacturing (CMC)
DICYCLOMINE HYDROCHLORIDE 2025-06-23
DICYCLOMINE HYDROCHLORIDE 2025-06-06
EPHEDRINE SULFATE 2025-03-11
EPHEDRINE SULFATE 2025-01-16
IC-GREEN 2024-12-05
Efficacy
DICYCLOMINE HYDROCHLORIDE 2024-11-15
DICYCLOMINE HYDROCHLORIDE 2024-11-01
DICYCLOMINE HYDROCHLORIDE 2024-11-01
SEC Filings
Pro
Loading...
Therapeutic Focus
Score weights: Approved drugs ×3, Phase 3 ×2, Phase 2 ×1, Phase 1 ×0.5
No indication data
Pipeline Strength Pro
Loading...
Active (1)
Discontinued (3)
Company Info
- First Approval
- 1959-02-09
- Latest
- 2024-12-05
- Applications
- 4